Executive Summary of the WHO Implementation Workshop in the Western Pacific region: Revised WHO Guidelines on Evaluation of Biosimilars
24–26 August 2026, Seoul, Republic of Korea
4 September 2026
| Report
WHO Team
Medicines and Health Products, Policies and Standards (HPS),
WHO Expert Committee on Biological Standardization
Number of pages
13
Reference numbers
WHO Reference Number: WHO/HSD/HPS/PSN/2026.7
Copyright
World Health Organization CC BY-NC-SA 3.0 IGO